For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Mind Medicine Inc (NASDAQ: MNMD) closed at $7.30 down -1.35% from its previous closing price of $7.40. In other words, the price has decreased by -$1.35 from its previous closing price. On the day, 0.86 million shares were traded.
Ratios:
For a deeper understanding of Mind Medicine Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.27 and its Current Ratio is at 7.27. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on January 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $23.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 25 ’25 when Barrow Robert sold 21,208 shares for $6.74 per share. The transaction valued at 142,942 led to the insider holds 856,556 shares of the business.
Karlin Daniel sold 6,836 shares of MNMD for $46,075 on Mar 25 ’25. The Chief Medical Officer now owns 446,177 shares after completing the transaction at $6.74 per share. On Mar 25 ’25, another insider, Sullivan Mark, who serves as the Chief Legal Officer of the company, sold 6,576 shares for $6.74 each. As a result, the insider received 44,322 and left with 316,621 shares of the company.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $10.44, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 11.74%, while the 200-Day Moving Average is calculated to be 7.90%.
Shares Statistics:
A total of 75.51M shares are outstanding, with a floating share count of 72.82M. Insiders hold about 3.61% of the company’s shares, while institutions hold 54.05% stake in the company.
Earnings Estimates
Investors are keenly observing as 7.0 analysts analyze and rate the current performance of Mind Medicine Inc (MNMD) in the stock market.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.3 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.19 and -$1.6 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.53, with 7.0 analysts recommending between -$0.6 and -$1.95.
